THE IMPORTANCE OF CHEMOTHERAPY IN THE MANAGEMENT STRATEGIES REGARDING HEPATIC METASTASES IN COLORECTAL CANCER

被引：0
|
作者：
Ginghina, Octav [1 ]
Dragomiroiu, George Traian Alexandru Burcea [2 ]
Negrei, Carolina [3 ]
Barca, Maria [2 ]
机构：
[1] Carol Davila Univ Med & Pharm, Sf Joan Hosp, Fac Med Dent, Dept Surg Oncol, Bucharest 042122, Romania
[2] Carol Davila Univ Med & Pharm, Fac Pharm, Dept Drug Control, Bucharest 020956, Romania
[3] Carol Davila Univ Med & Pharm, Fac Pharm, Dept Toxicol, Bucharest 020956, Romania
来源：
FARMACIA | 2014年 / 62卷 / 03期
关键词：
colorectal cancer; hepatic metastases; chemotherapy; POSITRON-EMISSION-TOMOGRAPHY; SURGICAL RESECTION; LIVER METASTASES; OXALIPLATIN; FLUOROURACIL; IRINOTECAN; LEUCOVORIN; CARCINOMA; STEATOHEPATITIS; MORTALITY;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The liver is the most common site for haematogenous metastases in colorectal cancer. Over the past ten years the survival rate in patients with hepatic metastases has significantly improved, mostly because of the development of new chemotherapy protocols, as well as new therapeutic agents. Overall, these are strengthening the effects of surgery, which in case of radical resection offers the best survival. Moreover, surgical control of liver metastatic extensive disease can combine resection with ablation therapies or staged methods. Today, the treatment of colorectal cancer liver metastases is essentially multidisciplinary, the medical oncologist together with the surgeon and the gastro-enterologist deciding the therapeutical sequence individualised for each patient.
引用
收藏
页码：429 / 435
页数：7
相关论文
共 50 条
  • [31] A randomized phase III study of hepatic arterial infusion chemotherapy with 5-fluorouracil and subsequent systemic chemotherapy versus systemic chemotherapy alone for colorectal cancer patients with curatively resected liver metastases (Japanese Foundation for Multidisciplinary Treatment of Cancer 32)
    Kusano, Mitsuo
    Aoyama, Toru
    Okabayashi, Koji
    Hirata, Koichi
    Tsuji, Yasushige
    Nakamori, Shoji
    Asahara, Toshimasa
    Ohashi, Yasuo
    Yoshikawa, Takaki
    Sakamoto, Junichi
    Oba, Koji
    Saji, Shigetoyo
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2018, 14 : S761 - S766
  • [32] Phase II study on hepatic arterial infusion chemotherapy using percutaneous catheter placement techniques for liver metastases from colorectal cancer (JFMC28 study)
    Arai, Yasuaki
    Aoyama, Toru
    Inaba, Yoshitaka
    Okabe, Haruumi
    Ihaya, Takashi
    Kichikawa, Kimihiko
    Ohashi, Yasuo
    Sakamoto, Junichi
    Oba, Koji
    Saji, Shigetoyo
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2015, 11 (01) : 41 - 48
  • [33] Surgical management of hepatic metastases of colorectal origin
    Gilson, N.
    Honore, C.
    Detry, O.
    De Roover, A.
    Coimbra, C.
    Kohnen, L.
    Polus, M.
    Piront, P.
    Van Daele, D.
    Honore, P.
    Meurisse, M.
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2009, 72 (03) : 321 - 326
  • [34] Splenic volume as a biomarker of hepatic damage after chemotherapy in patients with resected colorectal liver metastases (CRLM)
    Saez-Carlin, P.
    Garcia-Botella, A.
    Diez-Valladares, L., I
    Ortega Medina, L.
    Mendez, R.
    Gonzalez, J. C. M.
    Bernal, I
    Serrano Garcia, I
    Avellana, R.
    Torres Garcia, A. J.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (07) : 1180 - 1186
  • [35] Hepatic arterial infusion of oxaliplatin plus systemic chemotherapy and targeted therapy for unresectable colorectal liver metastases
    Boileve, Alice
    De Cuyper, Astrid
    Larive, Alicia
    Mahjoubi, Linda
    Najdawi, Milan
    Tazdait, Melodie
    Gelli, Maximiliano
    Tselikas, Lambros
    Smolenschi, Cristina
    Malka, David
    Pignon, Jean-Pierre
    Ducreux, Michel
    Boige, Valerie
    EUROPEAN JOURNAL OF CANCER, 2020, 138 : 89 - 98
  • [36] Hepatic Arterial Infusion Chemotherapy for Life Threatening Patients due to Liver Metastases from Colorectal Cancer with Cetuximab
    Yoshimatsu, Kazuhiko
    Osawa, Gakuji
    Yokomizo, Hajime
    Yano, Yuki
    Nakayama, Mao
    Okayama, Sachiyo
    Matsumoto, Atsuo
    Fujimoto, Takashi
    Morita, Satoru
    Naritaka, Yoshihiko
    HEPATO-GASTROENTEROLOGY, 2015, 62 (139) : 612 - 614
  • [37] Survival Outcomes of Patients with Colorectal Liver Metastases Following Hepatic Resection or Ablation in the Era of Effective Chemotherapy
    Nikfarjam, Mehrdad
    Shereef, Serene
    Kimchi, Eric T.
    Gusani, Niraj J.
    Jiang, Yixing
    Avella, Diego M.
    Mahraj, Rickhesvar P.
    Staveley-O'Carroll, Kevin F.
    ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (07) : 1860 - 1867
  • [38] Evaluating agreement regarding the resectability of colorectal liver metastases: a national case-based survey of hepatic surgeons
    Mohammad, Waleed M.
    Martel, Guillaume
    Mimeault, Richard
    Fairfull-Smith, Robert J.
    Auer, Rebecca C.
    Balaa, Fady K.
    HPB, 2012, 14 (05) : 291 - 297
  • [39] Evaluation and Management of Colorectal Cancer Hepatic Metastases
    Jacobson, Richard A.
    Bhama, Anuradha R.
    DISEASES OF THE COLON & RECTUM, 2021, 64 (07) : 777 - 780
  • [40] Surgical Management of Hepatic Metastases of Colorectal Cancer
    Smith, J. Joshua
    D'Angelica, Michael I.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2015, 29 (01) : 61 - +
12345